Latest Ribbon symbolism Stories
Inserm An Inserm team in Dijon directed by François Ghiringhelli (Inserm unit 866 ‘Lipids, nutrition and cancer’) is to publish an article this week in the Nature Medicine review. The article suggests that two chemotherapy drugs frequently used to treat digestive and breast cancers may encourage the development of tumors by modulating the anti-tumoral immune response. These results reveal how the immune system can then limit the effectiveness of some cancer chemotherapies. The...
LOS ANGELES, Dec. 5, 2012 /PRNewswire/ -- Researchers from the Revlon/UCLA Women's Cancer Research Program at UCLA's Jonsson Comprehensive Cancer Center (JCCC) reported an encouraging increase in progression-free survival (PFS, the length of time a patient is on treatment without tumor growth) for patients with breast cancer that was estrogen receptor positive (ER+), HER2-negative who were given a combination of the standard anti-estrogen treatment, letrozole, and a new experimental...
MONTCLAIR, N.J., Dec. 4, 2012 /PRNewswire/ -- MetaStat, Inc. ("MetaStat" or the "Company") (OTCBB: MTST), a life science company focused on understanding and treating systemic metastasis, today announced that John S. Condeelis, Ph.D., Chairman of MetaStat's Scientific Advisory Board, and Joan Jones, M.D., a member of MetaStat's Clinical Advisory Board, will be presenting data on the Company's licensed metastatic breast cancer markers at the CTRC-AACR 2012 San Antonio Breast Cancer...
UI finding might help improve 'liquid biopsy' approach for detecting cancer cells in blood A surprising discovery about the physical properties of cancer cells could help improve a new diagnostic approach—a liquid biopsy—that detects, measures, and evaluates cancer cells in blood. Cancer cells circulating in the bloodstream can form metastases—new tumors. Detecting these rare circulating cancer cells in a blood sample is much less invasive than a standard tumor biopsy, and could...
Prostate cancer drug shows promise in triple-negative and estrogen-positive breast cancer Breast cancers are defined by their drivers – estrogen and progesterone receptors (ER and PR) and HER2 are the most common, and there are drugs targeting each. When breast cancer has an unknown driver, it also has fewer treatment options – this aggressive form of breast cancer without ER, PR or HER2, which was thought not to be driven by hormones, is known as triple negative. A decade ago, work at...
Lee Rannals for redOrbit.com – Your Universe Online A common diabetes medication could help in preventing or treating ovarian cancer, according to research published in the journal CANCER. The study found that ovarian cancer patients who took the drug tended to live longer than those patients who did not take it. Previous research showed that metformin, which originated from the French Lilac plant, might have anticancer properties. In the new study, the researchers analyzed...
New research in The FASEB Journal suggests that a new detection method can accurately identify genetic switches lost and gained during the development of breast cancer tumors, resulting in earlier diagnosis Physicians may now be better at detecting breast cancer than ever before, but much more work remains to ensure accurate diagnosis is possible and especially to assess future risk. That's why researchers from Germany have been working to develop a new test of gene action to predict...
PRINCETON, N.J., Nov. 30, 2012 /PRNewswire/ -- In October, we see and hear a lot of breast cancer messages. And that's a good thing, because with the help of breast cancer awareness initiatives, most women over 40 understand the importance of having an annual mammogram. But here's something many people still may not know: for some women, an annual screening mammogram may not be enough. The SmartMamm program launched recently by Princeton Radiology Associates (PRA), an accredited...
TORONTO, Nov. 30, 2012 /PRNewswire/ - Responding to a report issued by CBC news November 27, 2012, representatives from Thermography Clinic Inc. want Canadians to be accurately informed about breast thermography, its benefits and limitations. Thermography, as a whole, should not be discredited simply because of the misinformation and low integrity of one company. Thermography Clinic Inc. and its affiliates have been consistently cautious and strict not to sell fear, and to stay...
NEWPORT NEWS, Va., Nov. 29, 2012 /PRNewswire/ -- The Radiological Society of North America (RSNA) Meeting, held annually in Chicago, Illinois, is one of the largest and most prestigious medical imaging conferences in the world. Top researchers often choose this venue to announce significant results from their clinical work. One of the most exciting areas of modern medicine being discussed at this year's meeting is molecular imaging. This week, many attendees expressed interest towards...
